Minneapolis
89°F
eEdition
News & Politics
Sports
Food & Culture
Business
Outdoors
Opinion
Things To Do
Obituaries
More of What Matters to Minnesota
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Minnesota State Top Stocks
Markets
Minnesota Stocks
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Agios Pharmaceuticals
(NQ:
AGIO
)
44.87
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
44.87
Bid (Size)
27.33 (1)
Ask (Size)
46.03 (3)
Prev. Close
44.87
Today's Range
44.87 - 44.87
52wk Range
19.80 - 50.35
Shares Outstanding
58,951,469
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Agios Pharmaceuticals' Rare Blood Disorder Drug Misses Primary Goal In Pediatric Study, Stock Slides
August 01, 2024
Agios Pharmaceuticals' Phase 3 ACTIVATE-KidsT study results reveal that mitapivat achieved a 28.1% transfusion reduction in children with PK deficiency compared to 11.8% with placebo. Secondary...
Via
Benzinga
Expert Ratings For Agios Pharmaceuticals
June 17, 2024
Via
Benzinga
Performance
YTD
+96.54%
+96.54%
1 Month
-6.03%
-6.03%
3 Month
+32.44%
+32.44%
6 Month
+65.57%
+65.57%
1 Year
+66.74%
+66.74%
More News
Read More
10 Health Care Stocks Whale Activity In Today's Session
June 13, 2024
Via
Benzinga
Novavax And Agios Pharmaceuticals Were Among The 10 Biggest Mid-Cap Gainers Last Week (June 1-June 7): Are These In Your Portfolio?
June 09, 2024
Via
Benzinga
Earnings Scheduled For February 15, 2024
February 15, 2024
Via
Benzinga
Earnings Preview: Agios Pharmaceuticals
February 14, 2024
Via
Benzinga
RBC Capital Maintains Outperform Rating for Agios Pharmaceuticals: Here's What You Need To Know
June 27, 2023
Via
Benzinga
June’s Biotech Boom: 3 Stocks to Buy for a Summertime Surge
June 05, 2024
Via
InvestorPlace
Why Is Agios Pharmaceuticals Stock Trading Higher On Monday?
June 03, 2024
Via
Benzinga
Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday
June 03, 2024
Via
Benzinga
Nvidia Again Boosts Nasdaq To Record Highs
May 28, 2024
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
May 28, 2024
Via
Benzinga
Why Is Agios Pharmaceuticals Stock Trading Higher On Tuesday?
May 28, 2024
Via
Benzinga
Exposures
Product Safety
Nvidia, Insmed, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
May 28, 2024
Via
Benzinga
Agios Pharmaceuticals Inks $905 Million Deal For Cancer Drug; Shares Poised To Break Out
May 28, 2024
Via
Investor's Business Daily
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
May 28, 2024
Via
Benzinga
Attention Biotech Investors - Stocks To Watch
May 16, 2024
Via
Benzinga
AGIO Stock Earnings: Agios Pharmaceuticals Beats EPS, Misses Revenue for Q1 2024
May 02, 2024
Via
InvestorPlace
The 3 Best Biotech Stocks to Buy Now: Q2 Edition
April 16, 2024
Via
InvestorPlace
Agios Pharmaceuticals Stock Earns RS Rating Upgrade; Hits Key Benchmark
February 23, 2024
Via
Investor's Business Daily
7 Biotech Stocks Fighting America’s Deadliest Diseases
February 08, 2024
Via
InvestorPlace
Why Is Blood Disorder Focused Agios Pharmaceuticals Stock Trading Higher Today?
January 03, 2024
Via
Benzinga
Agios Pharma Surges, And Retakes Its 200-Day Line, On Promising Test Results For Thalassemia Drug
January 03, 2024
Via
Investor's Business Daily
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 03, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
January 03, 2024
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.